drugset / Trial / NCT05896670
Safety and Efficacy of Licaminlimab Ophthalmic Solution for the Treatment of Dry Eye Disease
RandomizedParallel-groupDouble-blindTreatment
Summary
The goal of this clinical trial is to learn about licaminlimab (OCS-02) in the treatment of dry eye disease. The main question it aims to answer is if licaminlimab ophthalmic solution is more effective than vehicle in treating signs of dry eye disease.
Timeline
- Start
- 2023-11-29
- Primary completion
- 2024-03-27
- Completion
- 2024-03-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | licaminlimab | Monoclonal antibody | 60 mg/ml | Other |